Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Antipyretics on Synflorix Immunogenicity
NCT01235949Phase 4Completed
- Sponsor
- GSK
- Start
- Nov 2010
- Primary completion
- Mar 2012
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal infection, sponsored by GSK. Started Nov 2010; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT01235949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235949.